Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11279761 Anti-PD-L1 combinations for treating tumors

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11279761

Patent Inventor Names

Lixin Li0

Date of Patent

March 22, 2022

Patent Application Number

16029352

Date Filed

July 6, 2018

Patent Citations

‌

US Patent 10328158 Compounds and compositions for immunotherapy

Patent Citations Received

‌

US Patent 11834448 2-amino-quinoline derivatives

‌

US Patent 11633495 Compounds and compositions for immunotherapy

‌

US Patent 11633494 Compounds and compositions for immunotherapy

‌

US Patent 11786604 Compounds and compositions for treating HER2 positive tumors

‌

US Patent 11517567 Pharmaceutical compositions

Patent Primary Examiner

‌

Laura B Goddard

The present invention relates to therapeutic combinations and methods for treating cancers using combination therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11279761 Anti-PD-L1 combinations for treating tumors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API